Albumin BCP2
Bromcresol Purple Dye-Binding, Albumin. 510(k) K203530, from Abbott Ireland Diagnostics Division (Longford, IE). Product code CJW, class 2.
As of Nov 19, 2026, K203530 is an FDA 510(k) held by Abbott Ireland Diagnostics Division, substantially equivalent on Mar 18, 2022 after 471 days, with no recalls tied to it in FDA's recall database.
- Review time: 471 days
- Recalls: 0
The Albumin BCP2 assay is used for the quantitation of albumin in human serum or plasma on the ARCHITECT c System. The Albumin BCP2 assay is to be used as an aid in the diagnosis and treatment of numerous diseases involving primarily the liver or kidneys.
- AlbpK981814 · Abbott Laboratories · Jul 22, 1998
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 2, 2020
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1035
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files